{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:43Z","timestamp":1707525163168},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,26]]},"DOI":"10.7759\/cureus.42516","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T04:38:17Z","timestamp":1690432697000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Nodular Mantle Cell Lymphoma of the Gastrointestinal Tract Discovered During a Routine Colonoscopy With a Positive Response to R-CHOP Chemotherapy Regimen"],"prefix":"10.7759","author":[{"given":"Sukhjinder","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Valenta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gundip S","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preston","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwoon","family":"Huh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre E","family":"Manov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Wierman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe ES","year":"2001","unstructured":"Jaffe ES. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW (ed): IARC Press, Lyon, France; 2001."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0147-0272(96)80303-5","article-title":"Non-Hodgkin's lymphoma","volume":"20","author":"Smith M","year":"1996","unstructured":"Smith M. Non-Hodgkin's lymphoma. Curr Probl Cancer. 1996, 20:6-77. 10.1016\/S0147-0272(96)80303-5","journal-title":"Curr Probl Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3816\/clm.2003.n.025","article-title":"An update of the epidemiology of non-Hodgkin's lymphoma","volume":"4","author":"Chiu BC","year":"2003","unstructured":"Chiu BC, Weisenburger DD. An update of the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma. 2003, 4:161-8. 10.3816\/clm.2003.n.025","journal-title":"Clin Lymphoma"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/02841860500531682","article-title":"Epidemiology and etiology of non-Hodgkin lymphoma--a review","volume":"45","author":"Ekstr\u00f6m-Smedby K","year":"2006","unstructured":"Ekstr\u00f6m-Smedby K. Epidemiology and etiology of non-Hodgkin lymphoma--a review. Acta Oncol. 2006, 45:258-71. 10.1080\/02841860500531682","journal-title":"Acta Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras LR","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016, 66:443-59. 10.3322\/caac.21357","journal-title":"CA Cancer J Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-282632","article-title":"Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project","volume":"116","author":"Sant M","year":"2010","unstructured":"Sant M, Allemani C, Tereanu C, et al.. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010, 116:3724-34. 10.1182\/blood-2010-05-282632","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network","volume":"105","author":"Smith A","year":"2011","unstructured":"Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer. 2011, 105:1684-92. 10.1038\/bjc.2011.450","journal-title":"Br J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-764","article-title":"Racial differences in mantle cell lymphoma in the United States","volume":"14","author":"Wang Y","year":"2014","unstructured":"Wang Y, Ma S. Racial differences in mantle cell lymphoma in the United States. BMC Cancer. 2014, 14:764. 10.1186\/1471-2407-14-764","journal-title":"BMC Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820401)49:7<1429::AID-CNCR2820490720>3.0.CO;2-5","article-title":"Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma","volume":"49","author":"Weisenburger D","year":"1982","unstructured":"Weisenburger D, Kim H, Rappaport H. Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma. Cancer. 1982, 49:1429-1438. 10.1002\/1097-0142(19820401)49:7&lt;1429::AID-CNCR2820490720&gt;3.0.CO;2-5","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V59.2.317.317","article-title":"Malignant lymphoma of small cleaved lymphocytes of the follicular mantle zone","volume":"59","author":"Palutke M","year":"1982","unstructured":"Palutke M, Eisenberg L, Mirchandani I, et al.. Malignant lymphoma of small cleaved lymphocytes of the follicular mantle zone.  Blood. 1982, 59: 317-322. 10.1182\/blood.V59.2.317.317","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810915)48:6<1415::AID-CNCR2820480625>3.0.CO;2-N","article-title":"Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases","volume":"48","author":"Weisenburger D","year":"1981","unstructured":"Weisenburger D, Kim H, Rappaport H, et al..  Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases. Cancer. 1981, 48:1415-1425. 10.1002\/1097-0142(19810915)48:6&lt;1415::AID-CNCR2820480625&gt;3.0.CO;2-N","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma: a clinicopathologic study of 80 cases","volume":"89","author":"Argatoff L","year":"1997","unstructured":"Argatoff L, Connors J, Klasaet R, et al.. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood. 1997, 89:2067-2078. 10.1182\/blood.V89.6.2067","journal-title":"Blood"},{"key":"ref13","article-title":"Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23","volume":"7","author":"Dorfman DM","year":"1994","unstructured":"Dorfman DM, Pinkus GS. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Mod Pathol. 1994, 7:326-31.","journal-title":"Mod Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19980201)82:3<567::aid-cncr20>3.0.co;2-z","article-title":"Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors","volume":"82","author":"Bosch F","year":"1998","unstructured":"Bosch F, L\u00f3pez-Guillermo A, Campo E, et al.. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer. 1998, 82:567-575. 10.1002\/(sici)1097-0142(19980201)82:3&lt;567::aid-cncr20&gt;3.0.co;2-z","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10401","article-title":"The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease","volume":"94","author":"DiRaimondo F","year":"2002","unstructured":"DiRaimondo F, Albitar M, Huh Y, et al.. The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease. Cancer. 2002, 94:1721-30. 10.1002\/cncr.10401","journal-title":"Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2020.05.002","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"34","author":"Navarro A","year":"2020","unstructured":"Navarro A, Be\u00e0 S, Jares P, Campo E. Molecular pathogenesis of mantle cell lymphoma. Hematol Oncol Clin North Am. 2020, 34:795-807. 10.1016\/j.hoc.2020.05.002","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1101\/gad.7.3.331","article-title":"Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4","volume":"7","author":"Kato J","year":"1993","unstructured":"Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 1993, 7:331-42. 10.1101\/gad.7.3.331","journal-title":"Genes Dev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.2.753","article-title":"Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes","volume":"18","author":"Lundberg AS","year":"1998","unstructured":"Lundberg AS, Weinberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol. 1998, 18:753-61. 10.1128\/MCB.18.2.753","journal-title":"Mol Cell Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.124896","article-title":"The molecular pathogenesis of mantle cell lymphoma","volume":"58","author":"Vogt N","year":"2017","unstructured":"Vogt N, Dai B, Erdmann T, et al.. The molecular pathogenesis of mantle cell lymphoma. Leuk Lymphoma. 2017, 58:1530-1537. 10.1080\/10428194.2016.124896","journal-title":"Leuk Lymphoma"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0243-z","article-title":"Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma","volume":"25","author":"Agarwal R","year":"2019","unstructured":"Agarwal R, Chan YC, Tam CS, et al.. Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma. Nat Med. 2019, 25:119-29. 10.1038\/s41591-018-0243-z","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau1167","article-title":"Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma","volume":"11","author":"Zhang L","year":"2019","unstructured":"Zhang L, Yao Y, Zhang S, et al.. Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma. Sci Transl Med. 2019, 11:eaau1167. 10.1126\/scitranslmed.aau1167","journal-title":"Sci Transl Med"},{"key":"ref22","article-title":"TP53 mutations, but not deletion of TP53 and CDKN2A, have independent prognostic value in mantle cell lymphoma treated by the nordic (MCL2 and MCL3) regimen","volume":"102","author":"Eskelund CW","year":"2017","unstructured":"Eskelund CW, Dahl C, Hansen JW, et al.. TP53 mutations, but not deletion of TP53 and CDKN2A, have independent prognostic value in mantle cell lymphoma treated by the nordic (MCL2 and MCL3) regimen. Haematologica. 2017, 102:","journal-title":"Haematologica"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-779736","article-title":"TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy","volume":"130","author":"Eskelund CW","year":"2017","unstructured":"Eskelund CW, Dahl C, Hansen JW, et al.. TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy. Blood. 2017, 130:1903-10. 10.1182\/blood-2017-04-779736","journal-title":"Blood"},{"key":"ref24","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow SH","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, et al.. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Press, Geneva, Switzerland; 2008."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07124.x","article-title":"Advances in the understanding of mantle cell lymphoma","volume":"142","author":"Jares P","year":"2008","unstructured":"Jares P, Campo E. Advances in the understanding of mantle cell lymphoma. Br J Haematol. 2008, 142:149-65. 10.1111\/j.1365-2141.2008.07124.x","journal-title":"Br J Haematol"},{"key":"ref26","article-title":"The pathologist's view point. Part I--indolent lymphomas","volume":"85","author":"Pileri SA","year":"2000","unstructured":"Pileri SA, Ascani S, Sabattini E, et al.. The pathologist's view point. Part I--indolent lymphomas. Haematologica. 2000, 85:1291-307.","journal-title":"Haematologica"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12046","article-title":"Guidelines for the investigation and management of mantle cell lymphoma","volume":"159","author":"McKay P","year":"2012","unstructured":"McKay P, Leach M, Jackson R, Cook G, Rule S. Guidelines for the investigation and management of mantle cell lymphoma. Br J Haematol. 2012, 159:405-26. 10.1111\/bjh.12046","journal-title":"Br J Haematol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402272","article-title":"Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype","volume":"15","author":"Bernard M","year":"2001","unstructured":"Bernard M, Gressin R, Lefr\u00e8re F, et al.. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype. Leukemia. 2001, 15:1785-91. 10.1038\/sj.leu.2402272","journal-title":"Leukemia"},{"key":"ref29","article-title":"Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones","volume":"89","author":"Ott G","year":"1997","unstructured":"Ott G, Kalla J, Ott MM, Schryen B, Katzenberger T, M\u00fcller JG, M\u00fcller-Hermelink HK. Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood. 1997, 89:1421-9.","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2860","article-title":"Mantle cell lymphoma-advances in molecular biology, prognostication and treatment approaches","volume":"39","author":"Silkenstedt E","year":"2021","unstructured":"Silkenstedt E, Dreyling M. Mantle cell lymphoma-advances in molecular biology, prognostication and treatment approaches. Hematol Oncol. 2021, 39:31-8. 10.1002\/hon.2860","journal-title":"Hematol Oncol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05716.x","article-title":"Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network","volume":"131","author":"Tiemann M","year":"2005","unstructured":"Tiemann M, Schrader C, Klapper W, et al.. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol. 2005, 131:29-38. 10.1111\/j.1365-2141.2005.05716.x","journal-title":"Br J Haematol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4079","article-title":"The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma","volume":"107","author":"Katzenberger T","year":"2006","unstructured":"Katzenberger T, Petzoldt C, H\u00f6ller S, et al.. The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. Blood. 2006, 107:3407. 10.1182\/blood-2005-10-4079","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-117010","article-title":"Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group","volume":"111","author":"Determann O","year":"2008","unstructured":"Determann O, Hoster E, Ott G, et al.. Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group. Blood. 2008, 111:2385-7. 10.1182\/blood-2007-10-117010","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.02.011","article-title":"Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT)","volume":"65","author":"Rosenbluth BD","year":"2006","unstructured":"Rosenbluth BD, Yahalom J. Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT). Int J Radiat Oncol Biol Phys. 2006, 65:1185-91. 10.1016\/j.ijrobp.2006.02.011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.5.1288","article-title":"Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival","volume":"20","author":"Howard OM","year":"2002","unstructured":"Howard OM, Gribben JG, Neuberg DS, et al.. Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival. J Clin Oncol. 2002, 20:1288-1294. 10.1200\/JCO.2002.20.5.1288","journal-title":"J Clin Oncol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.133","article-title":"Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)","volume":"23","author":"Lenz G","year":"2005","unstructured":"Lenz G, Dreyling M, Hoster E, et al.. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol. 2005, 23:1984-92. 10.1200\/JCO.2005.08.133","journal-title":"J Clin Oncol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003805.pub2","article-title":"Chemotherapy plus rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma","volume":"2007","author":"Schulz H","year":"2007","unstructured":"Schulz H, Bohlius J, Skoetz N, et al.. Chemotherapy plus rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma. Cochrane Database Syst Rev. 2007, 2007:CD003805. 10.1002\/14651858.CD003805.pub2","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/167698-a-rare-case-of-nodular-mantle-cell-lymphoma-of-the-gastrointestinal-tract-discovered-during-a-routine-colonoscopy-with-a-positive-response-to-r-chop-chemotherapy-regimen","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:54Z","timestamp":1707508914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/167698-a-rare-case-of-nodular-mantle-cell-lymphoma-of-the-gastrointestinal-tract-discovered-during-a-routine-colonoscopy-with-a-positive-response-to-r-chop-chemotherapy-regimen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.42516","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,26]]}}}